isopropyl ((2S,4R)-1-acetyl-2-methyl-6-(1H-pyrrol-2-yl)-1,2,3,4-tetrahydroquinolin-4-yl)carbamate

ID: ALA4202664

PubChem CID: 135141503

Max Phase: Preclinical

Molecular Formula: C20H25N3O3

Molecular Weight: 355.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N1c2ccc(-c3ccc[nH]3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C

Standard InChI:  InChI=1S/C20H25N3O3/c1-12(2)26-20(25)22-18-10-13(3)23(14(4)24)19-8-7-15(11-16(18)19)17-6-5-9-21-17/h5-9,11-13,18,21H,10H2,1-4H3,(H,22,25)/t13-,18+/m0/s1

Standard InChI Key:  FVBZXKOSEIRNSU-SCLBCKFNSA-N

Molfile:  

     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   11.0639  -11.6460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7730  -12.0546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0639  -10.8288    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3590  -12.0546    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7730  -14.5062    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0639  -14.0976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0639  -13.2804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7730  -12.8718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4821  -13.2804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1871  -12.8718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8962  -13.2804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8962  -14.0976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1871  -14.5062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4821  -14.0976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3525  -13.2021    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6053  -12.8718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6893  -12.0573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4877  -11.8865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8963  -12.5956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3590  -14.5062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7730  -15.3234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0639  -15.7320    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4821  -15.7320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6499  -11.6460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9408  -12.0546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6499  -10.8288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  5 14  1  0
  9 14  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 15 19  1  0
 11 16  1  0
  6 20  1  1
 21 22  2  0
 21 23  1  0
  5 21  1  0
  8  2  1  1
 24 25  1  0
 24 26  1  0
  4 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4202664

    ---

Associated Targets(Human)

BRD2 Tchem Bromodomain-containing protein 2 (1296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 355.44Molecular Weight (Monoisotopic): 355.1896AlogP: 4.00#Rotatable Bonds: 3
Polar Surface Area: 74.43Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.42CX LogD: 2.42
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.87Np Likeness Score: -0.52

References

1. Shadrick WR, Slavish PJ, Chai SC, Waddell B, Connelly M, Low JA, Tallant C, Young BM, Bharatham N, Knapp S, Boyd VA, Morfouace M, Roussel MF, Chen T, Lee RE, Kiplin Guy R, Shelat AA, Potter PM..  (2018)  Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors.,  26  (1): [PMID:29170024] [10.1016/j.bmc.2017.10.042]

Source